CME Group price target raised to $304 from $280 at Barclays

Barclays raised the firm’s price target on CME Group (CME) to $304 from $280 and keeps an Equal Weight rating on the shares. The firm adjusted targets in the brokers, asset managers and exchanges group as part of its 2026. Market conditions “look constructive” going into 2026, particularly for the alternative asset managers and wealth brokers, the analyst tells investors in a research note. Barclays sees a more mixed outlook for the exchanges and traditional asset managers.